Inflammatory Bowel Disease Treatment Market Revenue 2025 to 2034
Inflammatory Bowel Disease Treatment Market Revenue 2025 to 2034
The inflammatory bowel disease treatment market size is projected to reach USD 35.88 billion by 2034, growing from USD 22.16 billion in 2025, at a CAGR of 5.5% during the forecast period from 2025 to 2034.
Report ID: 10124
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 21.01 Bn
Forecast Year,
USD USD 35.88 Bn
CAGR, 2025 -
5.5%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Inflammatory Bowel Disease Treatment Market Size Analysis
Inflammatory Bowel Disease Treatment Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Crohns Disease | 11.56 | 12.21 | 12.91 | 13.64 | 14.42 | 15.24 | 16.11 | 17.02 | 17.99 | 19.02 | 20.10 |
| Ulcerative Colitis | 9.45 | 9.95 | 10.48 | 11.03 | 11.61 | 12.22 | 12.86 | 13.54 | 14.25 | 15.00 | 15.79 |
Inflammatory Bowel Disease Treatment Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corticosteroids | 3.15 | 3.31 | 3.48 | 3.66 | 3.84 | 4.04 | 4.25 | 4.46 | 4.69 | 4.93 | 5.18 |
| Aminosalicylates | 2.52 | 2.65 | 2.79 | 2.93 | 3.09 | 3.25 | 3.41 | 3.59 | 3.78 | 3.97 | 4.18 |
| TNF Inhibitors | 5.25 | 5.56 | 5.88 | 6.22 | 6.58 | 6.96 | 7.36 | 7.78 | 8.23 | 8.71 | 9.21 |
| IL Inhibitors | 3.15 | 3.33 | 3.53 | 3.73 | 3.95 | 4.18 | 4.42 | 4.68 | 4.95 | 5.23 | 5.54 |
| JAK Inhibitors | 2.52 | 2.67 | 2.82 | 2.99 | 3.16 | 3.34 | 3.54 | 3.74 | 3.96 | 4.19 | 4.43 |
| Anti-Integrin | 2.10 | 2.22 | 2.34 | 2.47 | 2.61 | 2.75 | 2.91 | 3.07 | 3.24 | 3.42 | 3.61 |
| Others | 2.31 | 2.43 | 2.55 | 2.67 | 2.81 | 2.94 | 3.09 | 3.24 | 3.40 | 3.57 | 3.75 |
Inflammatory Bowel Disease Treatment Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 12.61 | 13.31 | 14.05 | 14.84 | 15.67 | 16.54 | 17.47 | 18.44 | 19.48 | 20.56 | 21.71 |
| Injectable | 8.40 | 8.86 | 9.33 | 9.83 | 10.36 | 10.92 | 11.50 | 12.12 | 12.77 | 13.45 | 14.18 |
Inflammatory Bowel Disease Treatment Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 10.51 | 11.09 | 11.72 | 12.37 | 13.07 | 13.80 | 14.57 | 15.39 | 16.25 | 17.16 | 18.12 |
| Retail Pharmacy | 7.35 | 7.75 | 8.17 | 8.61 | 9.08 | 9.57 | 10.09 | 10.63 | 11.21 | 11.81 | 12.45 |
| Online Pharmacy | 3.15 | 3.32 | 3.50 | 3.69 | 3.88 | 4.09 | 4.31 | 4.54 | 4.78 | 5.04 | 5.31 |
Inflammatory Bowel Disease Treatment Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 7.98 | 8.44 | 8.91 | 9.42 | 9.95 | 10.52 | 11.11 | 11.74 | 12.41 | 13.11 | 13.85 |
| Europe | 5.67 | 5.98 | 6.30 | 6.63 | 6.99 | 7.36 | 7.75 | 8.17 | 8.60 | 9.06 | 9.55 |
| Asia-Pacific | 4.62 | 4.89 | 5.17 | 5.46 | 5.78 | 6.11 | 6.46 | 6.83 | 7.22 | 7.64 | 8.07 |
| Latin America | 1.47 | 1.54 | 1.62 | 1.70 | 1.79 | 1.88 | 1.98 | 2.08 | 2.18 | 2.29 | 2.40 |
| Middle East & Africa | 1.26 | 1.32 | 1.38 | 1.45 | 1.52 | 1.59 | 1.67 | 1.75 | 1.83 | 1.92 | 2.01 |
Inflammatory Bowel Disease Treatment Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
